C9orf72 deficiency promotes microglial-mediated synaptic loss in aging and amyloid accumulation
Open accessAbstract
C9orf72 repeat expansions cause inherited amyotrophic lateral sclerosis (ALS)/frontotemporal dementia (FTD) and result in both loss of C9orf72 protein expression and production of potentially toxic RNA and dipeptide repeat proteins. In addition to ALS/FTD, C9orf72 repeat expansions have been reported in a broad array of neurodegenerative syndromes, including Alzheimer's disease. Here we show that C9orf72 deficiency promotes a change in the homeostatic signature in microglia and a transition to an inflammatory state characterized by an enhanced type I IFN signature. Furthermore, C9orf72-depleted microglia trigger age-dependent neuronal defects, in particular enhanced cortical synaptic pruning, leading to altered learning and memory behaviors in mice. Interestingly, C9orf72-deficient microglia promote enhanced synapse loss and neuronal deficits in a mouse model of amyloid accumulation while paradoxically improving plaque clearance. These findings suggest that altered microglial function due to decreased C9orf72 expression directly contributes to neurodegeneration in repeat expansion carriers independent of gain-of-function toxicities.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Microglial impairment from decreased C9ORF72 expression directly contributes to neurodegeneration in C9-ALS.
“Thus, the authors argued that microglial impairment from decreased C9ORF72 expression directly contributed to neurodegeneration in C9-ALS.362”
From Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets (2023) · cites this paper as [362]
Loss of C9orf72 promoted microglial gene signature transition from homeostatic to an inflammatory state characterized by an enhanced type I IFN signature.
“Results showed that loss of C9orf72 promoted microglial gene signature transition from homeostatic to an inflammatory state characterized by an enhanced type I IFN signature.”
From Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets (2023) · cites this paper as [362]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
The citation lists haven’t been fetched yet
References 99 · Cited by 147
- Authors
- Lall, D., Lorenzini, I., Mota, T. A., Bell, S., Mahan, T. E., Ulrich, J. D., Davtyan, H., Rexach, J. E., Muhammad, A. K. M. G., Shelest, O., Landeros, J., Vazquez, M., Kim, J., Ghaffari, L., O’Rourke, J. G., Geschwind, D. H., Blurton-Jones, M., Holtzman, D. M., Sattler, R., & Baloh, R. H.
- Affiliations
- Cedars-Sinai Medical Center (US)
- Barrow Neurological Institute (US)
- Washington University in St. Louis (US)
- University of California, Irvine (US)
- University of California, Los Angeles (US)
- Corresponding author
- Sattler, Rita
- Baloh, Robert H.
- ORCID
- Venue
- Neuron
- Publisher
- Elsevier BV
- Published
- 2021-07
- Volume
- 109
- Issue
- 14
- Pages
- 2275-2291.e8
- ISSN
- 0896-6273 (ISSN-L)
- PMC
- PMC8298293
- OpenAlex
- W3171061510
- Cited by
- 147
- References
- 99
- Citations by year
- 2026: 21 · 2025: 31 · 2024: 24 · 2023: 36 · 2022: 26 · 2021: 8 · 2020: 1
- FWCI
- 9.58
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 385 d)
- doi.org/10.15223/policy-017 (stm-asf)
- doi.org/10.15223/policy-037 (stm-asf)
- doi.org/10.15223/policy-012 (stm-asf)
- doi.org/10.15223/policy-029 (stm-asf)
- doi.org/10.15223/policy-004 (stm-asf)
- Locations
- Neuron (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- Howard Hughes Medical Institute
- National Institute on Aging (R01AG047644, P50AG016573, RF1AG055524, R01AG061895, RF1AG047644, P30AG066519, R01AG056303)
- National Institute of Neurological Disorders and Stroke (R01NS097545, R01NS085207, K08NS105916, R25NS065723, R01NS090934, UE5NS065723, RF1NS090934)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Neurology › Amyotrophic Lateral Sclerosis Research
- Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
- Keywords
- C9orf72, repeat expansion, microglia, synaptic pruning, synaptic loss, aging, amyloid accumulation, Alzheimer's disease, amyotrophic lateral sclerosis, frontotemporal dementia, type I interferon, neuroinflammation, learning and memory, plaque clearance, neurodegeneration
- MeSH terms
- C9orf72 Protein, Aging, Amyloid, Animals, Disease Models, Animal, Lysosomes, Synapses, Microglia, Mice, Knockout, DNA Repeat Expansion, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review